Clinical trial reportAnnals of oncology : official journal of the European Society for Medical OncologyPublished
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Annals of oncology : official journal of the European Society for Medical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Prostate-Specific Antigen; Receptors, Androgen; Ligands; Maximum Tolerated Dose; Aged; Aged, 80 and over; Middle Aged; Male; Androgen Receptor Antagonists; Prostatic Neoplasms, Castration-Resistant; Progression-Free Survival
- PubMed ID
- 39293515
- PubMed Central ID
- PMC12094577
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked